Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pakistan’s Getz Pharma Expects Profits From Open Trade With India

This article was originally published in PharmAsia News

Executive Summary

Pakistan’s Getz Pharma disagrees with its fellow drug makers and believes it can compete successfully with Indian counterparts in the open trade of pharmaceuticals.

Most Pakistani drug makers have called for an effective regulatory authority for their industry in Pakistan along with a competition even-handedness that would allow them to compete with India. Khalid Mahmood, CEO of Getz, already Pakistan’s largest drug exporter, believes open trade with India already affords an opportunity to increase exports through joint ventures, with an added benefit of achieving global standards. (Click here for more)

“Pharma Manufacturer Eyes Gains From Trade With India”Express Tribune (Pakistan) (11/27/11)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC076802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel